Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation

Molecular and Cellular Endocrinology

Volumn 343, Issue 1-2, 2011, Pages 7-17

  Masuda, Hiroko ^a   Otsuka, Fumio ^a   Matsumoto, Yoshinori ^a   Takano, Mariko ^a   Miyoshi, Tomoko ^a   Inagaki, Kenichi ^a   Shien, Tadahiko ^a   Taira, Naruto ^a   Makino, Hirofumi ^a   Doihara, Hiroyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Aromatase; Bone morphogenetic protein; Breast cancer; Estrogen receptor; Fibroblast growth factor; MAP kinase

Indexed keywords

AROMATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BOVINE SERUM ALBUMIN; CYCLIN DEPENDENT KINASE 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STERYL SULFATASE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

AROMATASE; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; FEMALE; FIBROBLAST GROWTH FACTOR 8; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD PROTEINS; STERYL-SULFATASE;

EID: 80051553193     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.037     Document Type: Article

References (54)

1. Adnane J., Gaudray P., Dionne C.A., Crumley G., Jaye M., Schlessinger J., Jeanteur P., Birnbaum D., Theillet C. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 1991, 6:659-663.
2. Alarmo E.L., Kallioniemi A. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?. Endocr. Relat. Cancer 2010, 17:R123-139.
3. Colditz G.A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl Cancer Inst. 1998, 90:814-823.
4. Crossley P.H., Martin G.R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 1995, 121:439-451.
5. Daphna-Iken D., Shankar D.B., Lawshe A., Ornitz D.M., Shackleford G.M., MacArthur C.A. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 1998, 17:2711-2717.
6. Dorkin T.J., Robinson M.C., Marsh C., Bjartell A., Neal D.E., Leung H.Y. FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 1999, 18:2755-2761.
7. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16:139-149.
8. Fortunati N., Catalano M.G., Boccuzzi G., Frairia R. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. Mol. Cell. Endocrinol. 2010, 316:86-92.
9. Foster P.A. Steroid metabolism in breast cancer. Minerva Endocrinol. 2008, 33:27-37.
10. Hayashi H., Ishisaki A., Imamura T. Smad mediates BMP-2-induced upregulation of FGF-evoked PC12 cell differentiation. FEBS Lett. 2003, 536:30-34.
11. Heikinheimo M., Lawshe A., Shackleford G.M., Wilson D.B., MacArthur C.A. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech. Dev. 1994, 48:129-138.
12. Helms M.W., Packeisen J., August C., Schittek B., Boecker W., Brandt B.H., Buerger H. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J. Pathol. 2005, 206:366-376.
13. Jaakkola S., Salmikangas P., Nylund S., Partanen J., Armstrong E., Pyrhonen S., Lehtovirta P., Nevanlinna H. Amplification of fgfr4 gene in human breast and gynecological cancers. Int. J. Cancer 1993, 54:378-382.
14. Keen J.C., Davidson N.E. The biology of breast carcinoma. Cancer 2003, 97:825-833.
15. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 2002, 277:4883-4891.
16. Lin C.Y., Strom A., Li Kong S., Kietz S., Thomsen J.S., Tee J.B., Vega V.B., Miller L.D., Smeds J., Bergh J., Gustafsson J.A., Liu E.T. Inhibitory effects of estrogen receptor β on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res. 2007, 9:R25.
17. MacArthur C.A., Lawshe A., Shankar D.B., Heikinheimo M., Shackleford G.M. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ. 1995, 6:817-825.
18. Marchal L., Luxardi G., Thome V., Kodjabachian L. BMP inhibition initiates neural induction via FGF signaling and Zic genes. Proc. Natl. Acad. Sci. USA 2009.
19. Marsh S.K., Bansal G.S., Zammit C., Barnard R., Coope R., Roberts-Clarke D., Gomm J.J., Coombes R.C., Johnston C.L. Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 1999, 18:1053-1060.
20. Mattila M.M., Harkonen P.L. Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev. 2007, 18:257-266.
21. Mattila M.M., Ruohola J.K., Valve E.M., Tasanen M.J., Seppanen J.A., Harkonen P.L. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 2001, 20:2791-2804.
22. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 1998, 18:136-141.
23. Miyoshi T., Otsuka F., Yamashita M., Inagaki K., Nakamura E., Tsukamoto N., Takeda M., Suzuki J., Makino H. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells. Mol. Cell. Endocrinol. 2010, 325:84-92.
24. Nakamura Y., Tensho K., Nakaya H., Nawata M., Okabe T., Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 2005, 36:399-407.
25. Nilsson E.M., Brokken L.J., Harkonen P.L. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death. Exp. Cell Res. 2010, 316:800-812.
26. Otsuka F. Multiple endocrine regulation by bone morphogenetic protein system. Endocr. J. 2010, 57:3-14.
27. Otsuka F., McTavish K., Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol. Reprod. Dev. 2011, 78:9-21.
28. Penault-Llorca F., Bertucci F., Adelaide J., Parc P., Coulier F., Jacquemier J., Birnbaum D., deLapeyriere O. Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer 1995, 61:170-176.
29. Pouliot F., Blais A., Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res. 2003, 63:277-281.
30. Razandi M., Pedram A., Greene G.L., Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 1999, 13:307-319.
31. Reinhold M.I., Abe M., Kapadia R.M., Liao Z., Naski M.C. FGF18 represses noggin expression and is induced by calcineurin. J. Biol. Chem. 2004, 279:38209-38219.
32. Ruohola J.K., Viitanen T.P., Valve E.M., Seppanen J.A., Loponen N.T., Keskitalo J.J., Lakkakorpi P.T., Harkonen P.L. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res. 2001, 61:4229-4237.
33. Sasano H., Suzuki T., Nakata T., Moriya T. New development in intracrinology of breast carcinoma. Breast Cancer 2006, 13:129-136.
34. Selcer K.W., Hegde P.V., Li P.K. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Cancer Res. 1997, 57:702-707.
35. Shimasaki S., Moore R.K., Otsuka F., Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 2004, 25:72-101.
36. Shupnik M.A. Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer?. Breast Cancer Res. 2007, 9:107.
37. Stark G.R., Taylor W.R. Control of the G2/M transition. Mol. Biotechnol. 2006, 32:227-248.
38. Subramanian A., Salhab M., Mokbel K. Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res. Treat. 2007.
39. Sugiura K., Su Y.Q., Diaz F.J., Pangas S.A., Sharma S., Wigglesworth K., O'Brien M.J., Matzuk M.M., Shimasaki S., Eppig J.J. Oocyte-derived BMP15 and FGFs cooperate to promote glycolysis in cumulus cells. Development 2007, 134:2593-2603.
40. Sun X., Meyers E.N., Lewandoski M., Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 1999, 13:1834-1846.
41. Taguchi Y., Koslowski M., Bodenner D.L. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl. Recept. 2004, 2:5.
42. Takahashi M., Otsuka F., Miyoshi T., Otani H., Goto J., Yamashita M., Ogura T., Makino H., Doihara H. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J. Endocrinol. 2008, 199:445-455.
43. Tanaka A., Miyamoto K., Matsuo H., Matsumoto K., Yoshida H. Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett. 1995, 363:226-230.
44. Tanaka A., Kamiakito T., Takayashiki N., Sakurai S., Saito K. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch. 2002, 441:380-384.
45. Tanaka A., Miyamoto K., Minamino N., Takeda M., Sato B., Matsuo H., Matsumoto K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA 1992, 89:8928-8932.
46. Tanaka A., Furuya A., Yamasaki M., Hanai N., Kuriki K., Kamiakito T., Kobayashi Y., Yoshida H., Koike M., Fukayama M. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res. 1998, 58:2053-2056.
47. Theillet C., Adelaide J., Louason G., Bonnet-Dorion F., Jacquemier J., Adnane J., Longy M., Katsaros D., Sismondi P., Gaudray P., et al. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosom. Cancer 1993, 7:219-226.
48. Valve E.M., Tasanen M.J., Ruohola J.K., Harkonen P.L. Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus. Biochem. Biophys. Res. Commun. 1998, 250:805-808.
49. Warren S.M., Brunet L.J., Harland R.M., Economides A.N., Longaker M.T. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003, 422:625-629.
50. Watson C.S., Campbell C.H., Gametchu B. The dynamic and elusive membrane estrogen receptor-alpha. Steroids 2002, 67:429-437.
51. Yamamoto T., Saatcioglu F., Matsuda T. Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology 2002, 143:2635-2642.
52. Ye L., Bokobza S.M., Jiang W.G. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review). Int. J. Mol. Med. 2009, 24:591-597.
53. Yoshimura N., Sano H., Hashiramoto A., Yamada R., Nakajima H., Kondo M., Oka T. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin. Immunol. Immunopathol. 1998, 89:28-34.
54. Zammit C., Coope R., Gomm J.J., Shousha S., Johnston C.L., Coombes R.C. Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer. Br. J. Cancer 2002, 86:1097-1103.